Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank upgrades Astrazeneca to 'hold'

Tue 15 Sep 2026 12:42

(Sharecast News) - Deutsche Bank upgraded Astrazeneca from 'sell' to 'hold' on Tuesday and nudged its price target up from 11,500p to 11,700p, saying the risk‑reward scenario had shifted following last week's negative SERENA-4 readout and a period of underperformance against European large‑cap peers. The broker noted that the stock has fallen around 3% in absolute terms since its downgrade last October and lagged the sector by roughly 10% on an FX‑adjusted basis.

It said part of the weakness reflected factors it had anticipated - including second‑half event risk and patent‑cliff concerns - while other pressures, such as developments around Wainua and Bristol Myers, were less expected.

Deutsche Bank added that while it did not view Monday's sector bounce as fundamentally driven or likely to persist into the US mid‑terms, Astrazeneca's valuation now looked more balanced, prompting the move to 'hold'.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Fri 16 Oct 2026 10:52
RBC Capital downgrades Lloyds to 'sector perform'
(Sharecast News) - RBC Capital Markets downgraded Lloyds Banking Group on Friday to 'sector perform' from 'outperform' and cut the price target to 115p from 124p.
Fri 16 Oct 2026 09:31
Canaccord Genuity starts Pulsar Helium at 'speculative buy'
(Sharecast News) - Canaccord Genuity initiated coverage of Pulsar Helium with a 'speculative buy' rating and a 150p target price on Friday, noting the group was advancing a major primary helium resource at its Topaz project in Minnesota.
Fri 16 Oct 2026 07:59
Wise lifts full-year revenue outlook
(Sharecast News) - Wise lifted its full-year outlook for revenue growth on Friday as it posted a jump in second-quarter revenue.
Fri 16 Oct 2026 07:41
Berenberg hikes target price on Bridgepoint
(Sharecast News) - Analysts at Berenberg lifted their target price on Bridgepoint to 455p from 360p on Friday, citing a fresh round of upgrades following the group's unscheduled trading update on 7 October.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026